Medical Device Developer Launches Unit To Advance Neurostimulation Technology

NDI Medical, a leader in the
development and commercialization of neurostimulation products for the medical
device industry, today announced it has formed a new business unit to help
companies and researchers develop and market neurostimulation products for
neurological and cardiac applications that use implantable pulse generator
(IPG) technology. The company's new wireless, rechargeable IPG, the
Micropulse, sits at the core of the Micropulse Business Unit. It is the
smallest device of its kind available to companies and researchers developing
neurostimulation products.


"The Micropulse IPG can be customized to achieve the clinical, therapeutic
and business objectives of our customers," said Richard P. Kuntz, the General
Manager of the business unit.


"The Micropulse technology platform is a complete neurostimulation system,
including the IPG, implantable leads, surgical delivery tools and devices to
program and control the IPG. Our system makes NDI Medical an ideal one-stop
solution for companies and researchers pursuing the neurostimulation market,"
Kuntz said.


Neurostimulation is being used increasingly by clinicians to treat a
variety of medical problems, including pain management, cardiac therapies,
obesity management, mental disorders, respiratory illnesses, pelvic
healthcare, and paralysis.


The Micropulse Business Unit is working with several customers that sought
to accelerate and enhance the development of their neurostimulation products,
according to Geoffrey Thrope, president and CEO of NDI Medical.


Thrope said NDI Medical is exploring opportunities with start-up
neurostimulation companies; medical device companies pursuing the
neurostimulation market; neurostimulation researchers and clinicians; and
neurostimulation companies seeking product advancements.


"NDI Medical is the only company with the requisite technology, products,
clinical expertise, and regulatory experience to get companies and researchers
from development to market efficiently," Kuntz said.


NDI Medical hired Kuntz, a 15-year medical device industry veteran, last
year to head its new business unit. He previously was vice president of
operations for Cyberonics, Inc. and Northstar Neuroscience, Inc. and has
worked for Johnson & Johnson's subsidiary Codman & Shurtleff, Inc. and
Spacelab Medical, Inc.


"Richard brings to NDI Medical extensive experience in developing and
manufacturing IPGs for industry leaders and startups," said Thrope.
"Neurostimulation devices can dramatically improve the lives of patients
who face a variety of medical issues," Thrope said. "NDI Medical's mission is
to deliver the client's clinical application to market as soon as reasonably
possible by customizing our Micropulse platform technology to fit the
application. Additionally, our core competencies in neurostimulation product
development and commercialization provide added strategic value in technology
development, reimbursement assessments, project management, regulatory, and
clinical studies support. Our Micropulse Business Unit is truly a one-stop
neurostimulation shop for the neurostimulation marketplace."


About NDI Medical


Founded in 2002, NDI Medical is a leader in the development and
manufacture of neurostimulation medical devices. The company's flagship
product, the Micropulse IPG, is the smallest available two-channel,
rechargeable IPG, which can be customized and scaled to achieve the
therapeutic objectives of its partners. NDI Medical has an experienced team of
business executives, engineers and regulatory professionals who work with
companies and researchers to accelerate and enhance the commercialization of
promising neurostimulation products. NDI Medical is headquartered in the
eastern suburbs of Cleveland, Ohio.


ndimedical